Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0J3AV
|
||||
Former ID |
DIB010202
|
||||
Drug Name |
PEG-LPA-2
|
||||
Synonyms |
Leptin receptor antagonists (cancer/endometriosis); PEG-LPA-2; Leptin receptor antagonists (cancer/endometriosis), CRT; Leptin receptor antagonists (cancer/endometriosis), Cancer Research Technology; PEGylated leptin receptor antagonists (cancer/endometriosis), CRT; PEGylated leptin receptor antagonists (cancer/endometriosis), Cancer Research Technology
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543464] | ||
Company |
Boston Biomedical Research Inst
|
||||
Target and Pathway | |||||
Target(s) | Leptin receptor | Target Info | Antagonist | [543464] | |
Pathway Interaction Database | Signaling events mediated by PTP1B | ||||
WikiPathways | Leptin signaling pathway | ||||
AMPK Signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.